Skip to main content
C

Celestra Inc. — Investor Relations & Filings

Ticker · 352770 ISIN · KR7352770002 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 378 across all filing types
Latest filing 2025-04-16 AGM Information
Country KR South Korea
Listing KO 352770

About Celestra Inc.

https://celestrahealth.com/

Celestra Inc. develops and commercializes digital biomarkers for monitoring neurological conditions. The company's core product is the Celestra Health platform, an FDA-designated Class II medical device that provides quantitative gait analysis for patients in their natural environment. The platform utilizes wearable smart insoles equipped with gyroscopes, accelerometers, and pressure sensors to collect movement data. This data is processed by a cloud-based system using advanced machine learning algorithms to measure over 200 aspects of a patient's gait. The system is designed to detect subtle changes in disease progression for conditions such as Multiple Sclerosis and Parkinson’s Disease earlier than traditional clinical assessments. It offers laboratory-grade accuracy, providing clinicians with actionable insights through a proprietary composite index and enabling pharmaceutical firms to assess drug therapy effectiveness more efficiently.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a shareholder meeting (주주총회소집결의) for the company 'Celestra'. It outlines the date, time, location, and agenda items (such as the appointment of an outside director) for an upcoming Extraordinary General Meeting. This type of document is a standard proxy-related notification sent to shareholders to inform them of an upcoming meeting and the matters to be voted upon, which falls under the Proxy Solicitation & Information Statement category.
2025-04-16 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date for an upcoming Extraordinary General Meeting (EGM) to determine shareholder voting rights. It is not the meeting materials themselves, but a formal notice of the record date. Given the nature of the announcement regarding shareholder meetings and voting, it fits best under the general regulatory filing category for corporate actions.
2025-04-16 Korean
사채원리금미지급발생 (제2회차 CB)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory disclosure regarding a 'Default on Principal and Interest' (사채원리금미지급발생) for a convertible bond (CB). It details the amount, the reason (default due to audit opinion disclaimer), and the company's response. This is a specific regulatory filing required by the Korea Exchange (KRX) for material events, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A, dividends, or share repurchases.
2025-04-11 Korean
기타경영사항(자율공시) (자기사채(제4,5회차 전환사채) 소각 결정)
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from a Korean company (Celestra) regarding the decision to cancel (retire) its own convertible bonds (4th and 5th series). This type of corporate action, involving the cancellation of debt instruments, falls under capital structure changes. Since there is no specific category for 'Debt Cancellation' or 'Bond Retirement' in the provided list, and it is a formal regulatory disclosure of a corporate event, it is best classified as a Regulatory Filing (RNS).
2025-04-10 Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제4회차)
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from a Korean company (Celestra) regarding the acquisition of convertible bonds before maturity. It details the specific bond series, the acquisition amount, the reason for acquisition (redemption request due to loss of benefit of time), and the method of acquisition. This falls under capital structure changes and financing updates, specifically related to debt instruments, which is best classified as CAP (Capital/Financing Update).
2025-04-09 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the resignation of an outside director (사외이사). This falls under the category of changes in board or management personnel.
2025-04-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.